Search results
Author(s):
Shaojie Chen
,
Boris Schmidt
,
Stefano Bordignon
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained tachyarrhythmia. Catheter ablation is the most effective treatment for AF, and pulmonary vein isolation (PVI) is the cornerstone of all AF ablation strategies. The use of a radiofrequency (RF) catheter in combination with a 3D electro-anatomical mapping system is the most well established approach to AF ablation. However, manipulating a RF…
View more
Author(s):
Fehmi Keçe
,
Katja Zeppenfeld
,
Serge A Trines
Added:
3 years ago
Catheter ablation is an effective strategy to maintain sinus rhythm in patients with symptomatic atrial fibrillation (AF), which has evolved from a highly specialised technique to a first-line therapy.1–3 The cornerstone of ablation is pulmonary vein isolation (PVI).4 Over the last decade, ablation devices have undergone technical improvements, aiming for better lesion durability and ablation…
View more
Author(s):
Jean-Baptiste Gourraud
,
Jason G Andrade
,
Laurent Macle
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia observed in clinical practice, occurring in approximately 2 % of the general population.1–3 A progressive increase in both the prevalence and incidence of AF has been demonstrated in recent years, defining AF as a major economic and public health issue.1
The identification of sites of AF initiation and/or maintenance within…
View more
Author(s):
Karl-Heinz Kuck
,
Andreas Metzner
Added:
3 years ago
Catheter-based ablation of atrial fibrillation (AF) is an established treatment option for symptomatic patients who are refractory to drug-based treatment, as implemented in the latest guidelines for the management of AF.1 The accepted and recommended cornerstone of all ablation strategies for AF is electrical isolation of the pulmonary veins (PV).2 However, in addition to PV isolation (PVI),…
View more
Added:
1 month ago
Source:
EHRA 2024
The European Heart Rhythm Association (EHRA) Congress has announced four late-breaking clinical trial sessions to be presented in April.EHRA 24 will take place in Berlin and online from the 7th to the 9th April 2024. Access the full programme here.Late-Breaking Science: ClinicalSunday 7th April, 13:45 – 14:45 Central European TimeArtificial intelligence-enabled single-lead ambulatory ECG can…
View more
Author(s):
Nitin Kulkarni
,
Wilber Su
,
Richard Wu
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia and the prevalence is increasing every year; it is expected to affect 12 million Americans by the year 2030.1 A significant portion of patients fail to maintain sinus rhythm with use of anti-arrhythmic drug therapy and are referred for catheter ablation. Ablation is currently indicated for patients with paroxysmal (class I) or…
View more
Added:
2 months ago
Source:
AF Symposium, Jordan Rance
The AF symposium has announced two late-breaking clinical trial sessions set to be presented in Boston from February 1st to February 3rd this year. The AF symposium is dedicated to bringing together the world’s leading scientists to share the latest advances in atrial fibrillation.Thursday 1st February 2024Late Breaking Clinical Science Session I6:00 – 7:00pmAcute Kidney Injury Resulting From…
View more
Author(s):
Konstantinos C Siontis
,
Hakan Oral
Added:
3 years ago
Advanced catheter-based technologies employed for the ablation of symptomatic atrial fibrillation (AF) have revolutionised the management of this common sustained arrhythmia. In the late 1990s, premature depolarisations originating from the myocardial sleeves within the pulmonary veins were recognised to initiate AF. This landmark discovery rendered pulmonary vein isolation (PVI) as the…
View more
Author(s):
Gian-Battista Chierchia
,
Saverio Iacopino
,
Carlo de Asmundis
Added:
3 years ago
Pulmonary vein (PV) isolation is currently an established treatment for drug-resistant AF.1 A left common PV (LCPV) is present in 9–83 % of the patients, depending on the definition used,2,3 and counts as the most frequent PV variation, followed by a right accessory middle vein. In recent years, cryoballoon (CB) ablation has emerged as a valid alternative to traditional point-by-point…
View more
Author(s):
Yoga Waranugraha
,
Ardian Rizal
,
Mohammad Saifur Rohman
,
et al
Added:
1 year ago